oasis 1 oral semaglutide 50 mg obesity nejm 2023 results of #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj 𝗠𝗼𝘀𝘁 𝗽𝗲𝗼𝗽𝗹𝗲 𝗮𝘀𝘀𝘂𝗺𝗲 𝘁𝗵𝗲 𝘄𝗲𝗶𝗴𝗵𝘁

In the search for interventions addressing brain dysfunction underlying cognitive impairment in SZ and bipolar illness, we look comprehensively at the brain and beyond to the potential role of dysfunctional central and systemic metabolism

Jeffrey Millstein is an internist and regional medical director for Penn Primary Care.

Social media plays an outsized role in this region, where influencer endorsements are the primary catalyst for the "No Makeup" trend, encouraging consumers to invest in ingestibles that create a naturally radiant "inner glow" finish

doi:10.14309/ajg.0000000000002801

When including patients who discontinued treatment, the average weight loss was lower at 23.7% of total body weight at Week 68